$AUR
Aurora Innovation, Inc. Stock $aur

$aur Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000182810822000046 Filed on May 12, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$42.00M	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$31.05M	$32.68M
YoY Change	-4.98%
% of Gross Profit
Research & Development	$154.1M	$159.1M
YoY Change	-3.15%
% of Gross Profit
Depreciation & Amortization	$5.786M	$5.994M
YoY Change	-3.47%
% of Gross Profit
Operating Expenses	$185.1M	$191.8M
YoY Change	-3.47%
Operating Profit	-$143.1M	-$191.8M
YoY Change	-25.36%
Interest Expense	$66.39M	-$2.020M
YoY Change	-3386.68%
% of Operating Profit
Other Income/Expense, Net	-$53.00K	-$2.015M
YoY Change	-97.37%
Pretax Income	-$76.81M	-$191.3M
YoY Change	-59.84%
Income Tax	$2.000K	-$2.644M
% Of Pretax Income
Net Earnings	-$76.81M	-$188.6M
YoY Change	-59.28%
Net Earnings / Revenue	-182.88%
Basic Earnings Per Share	-$0.07	-$0.39
Diluted Earnings Per Share	-$0.07	-$0.39
COMMON SHARES
Basic Shares Outstanding	1.126B shares	483.6M shares
Diluted Shares Outstanding	1.126B shares	483.6M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.469B	$760.0K
YoY Change	193153.82%
Cash & Equivalents	$504.3M	$757.6K
Short-Term Investments	$964.4M
Other Short-Term Assets	$23.14M	$1.510M
YoY Change	1432.65%
Inventory
Prepaid Expenses		$1.506M
Receivables	$27.04M
Other Receivables	$0.00
Total Short-Term Assets	$1.519B	$2.264M
YoY Change	67002.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$95.98M
YoY Change
Goodwill	$1.114B
YoY Change
Intangibles	$618.1M
YoY Change
Long-Term Investments		$977.5M
YoY Change
Other Assets	$20.46M
YoY Change
Total Long-Term Assets	$2.015B	$979.2M
YoY Change	105.79%
TOTAL ASSETS
Total Short-Term Assets	$1.519B	$2.264M
Total Long-Term Assets	$2.015B	$979.2M
Total Assets	$3.534B	$981.4M
YoY Change	260.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.303M	$37.95K
YoY Change	11238.3%
Accrued Expenses	$15.72M	$359.7K
YoY Change	4269.89%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$90.00K
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$49.02M	$2.016M
YoY Change	2331.87%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$1.064M	$70.30M
YoY Change	-98.49%
Total Long-Term Liabilities	$1.064M	$70.30M
YoY Change	-98.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$49.02M	$2.016M
Total Long-Term Liabilities	$1.064M	$70.30M
Total Liabilities	$239.5M	$71.41M
YoY Change	235.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.168B	-$1.202M
YoY Change	97107.59%
Common Stock	$11.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.295B	$520.2M
YoY Change
Total Liabilities & Shareholders Equity	$3.534B	$981.4M
YoY Change	260.08%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$76.81M	-$188.6M
YoY Change	-59.28%
Depreciation, Depletion And Amortization	$5.786M	$5.994M
YoY Change	-3.47%
Cash From Operating Activities	-$135.8M	-$151.0M
YoY Change	-10.04%
INVESTING ACTIVITIES
Capital Expenditures	$5.513M	$3.381M
YoY Change	63.06%
Acquisitions	$0.00	-$294.4M
YoY Change	-100.0%
Other Investing Activities	-$966.1M	-$977.5M
YoY Change	-1.17%
Cash From Investing Activities	-$971.6M	$291.1M
YoY Change	-433.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.921M	$617.0K
YoY Change	211.35%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.835M	$398.5M
YoY Change	-99.54%
NET CHANGE
Cash From Operating Activities	-$135.8M	-$151.0M
Cash From Investing Activities	-$971.6M	$291.1M
Cash From Financing Activities	$1.835M	$398.5M
Net Change In Cash	-$1.106B	$538.6M
YoY Change	-305.28%
FREE CASH FLOW
Cash From Operating Activities	-$135.8M	-$151.0M
Capital Expenditures	$5.513M	$3.381M
Free Cash Flow	-$141.3M	-$154.4M
YoY Change	-8.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001828108
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-40216
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	Aurora Innovation, Inc.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4432907000	USD
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	280000	USD
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1562265
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1654 Smallman St.
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Pittsburgh
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	15222
CY2022Q1	dei	City Area Code CityAreaCode	888
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	583-9506
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	504313000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1610135000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1677444000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	95984000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	93517000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	280000	USD
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	964416000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	27036000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	32538000	USD
CY2022Q1	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	0	USD
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	10726000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22863000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	23765000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	1518908000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	150624000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	151278000	USD
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	16100000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	15832000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	20456000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21050000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	618149000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	617200000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	1113766000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	1113766000	USD
CY2022Q1	us-gaap	Assets Assets	3533987000	USD
CY2021Q4	us-gaap	Assets Assets	3690087000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4303000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7901000	USD
CY2022Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1369000	USD
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	540000	USD
CY2022Q1	aur	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	31210000	USD
CY2021Q4	aur	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	70006000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12134000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12274000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	49016000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	90721000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	133251000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	134551000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3905000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3905000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1064000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1150000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	239484000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	348385000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	11000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	11000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4464191000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	154090000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1675000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1168024000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1091216000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3294503000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3341702000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3533987000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3690087000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41998000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	159109000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31052000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32680000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	185142000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	191789000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-143144000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-191789000	USD
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	581000	USD
CY2021Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	570000	USD
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	65810000	USD
CY2021Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2022Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	53000	USD
CY2021Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	44000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-76806000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-191263000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2644000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-76808000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-188619000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-188619000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-1675000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	0	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1675000	USD
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1126147810	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1126147810	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	483555367	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	483555367	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-76808000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-78483000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-188619000	USD
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	290300547	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	763283000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-276579000	USD
CY2021Q1	aur	Temporary Equity Stock Issued During Period Shares Acquisitions Price Per Share TemporaryEquityStockIssuedDuringPeriodSharesAcquisitionsPricePerShare	9.06
CY2021Q1	aur	Temporary Equity Stock Issued During Period Shares Acquisitions TemporaryEquityStockIssuedDuringPeriodSharesAcquisitions	110437359	shares
CY2021Q1	aur	Temporary Equity Stock Issued During Period Value Acquisitions TemporaryEquityStockIssuedDuringPeriodValueAcquisitions	1000000000	USD
CY2021Q1	aur	Temporary Equity Stock Issued During Period Shares New Issues Price Per Share TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesPricePerShare	9.06
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	2138000	USD
CY2021Q1	aur	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	44174944	shares
CY2021Q1	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	397862000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	937669000	USD
CY2021Q1	aur	Adjustments To Additional Paid In Capital Purchase Consideration Allocated To Non Cash Compensation Expense AdjustmentsToAdditionalPaidInCapitalPurchaseConsiderationAllocatedToNonCashCompensationExpense	7873000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	702000	USD
CY2021Q1	aur	Stock Issued During Period Value Stock Options Exercised Early StockIssuedDuringPeriodValueStockOptionsExercisedEarly	111000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39040000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-188619000	USD
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	444912850	shares
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2161145000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	520197000	USD
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3341702000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2026000	USD
CY2022Q1	aur	Stock Issued During Period Value Stock Options Exercised Early StockIssuedDuringPeriodValueStockOptionsExercisedEarly	11000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	29247000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-78483000	USD
CY2022Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3294503000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-76808000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-188619000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5786000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5994000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	6862000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4824000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7655000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4767000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-37545000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-13011000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-6322000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4326000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-135813000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	6070000	USD
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	28000	USD
CY2021Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	29247000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	36895000	USD
CY2022Q1	us-gaap	Severance Costs1 SeveranceCosts1	0	USD
CY2021Q1	us-gaap	Severance Costs1 SeveranceCosts1	7873000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2637000	USD
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	65810000	USD
CY2021Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-5502000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	0	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-11730000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-844000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	772000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-150974000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5513000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3381000	USD
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-294439000	USD
CY2022Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	966063000	USD
CY2021Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-971576000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	291058000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1921000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	617000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	397862000	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	86000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1835000	USD
CY2022Q1	aur	Number Of Equity Compensation Plans NumberOfEquityCompensationPlans	4	incentivePlan
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	398479000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1105554000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	538563000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1626247000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	399828000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	520693000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	938391000	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	Use of EstimatesThe preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
CY2022Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	504110000	USD
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:18pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties Including Business and Credit Concentrations</span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s principal operations are the research, design, and implementation of the Aurora Driver. The Company is currently researching and developing its proprietary technology with the goal of commercializing the Aurora Driver. The Company expects that it will need to raise additional capital to support its development and commercialization activities. Risks and uncertainties to the Company’s operations include failing to secure additional funding and the threat of other companies developing and bringing to market similar technology at an earlier time than the Company.</span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents and short-term investments. The Company maintains its cash and cash equivalents at U.S. commercial banks. Cash and cash equivalents deposited with domestic commercial banks generally exceed the Federal Deposit Insurance Corporation insurable limit. To date, the Company has not experienced any losses on its deposits of cash and cash equivalents.</span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically invests in U.S. Treasury securities and classifies its short-term investments as available-for-sale. In general, these investments are free of trading restrictions. The Company carries these at fair value, based on quoted market prices or other readily available market information and recognizes gains and losses when realized.</span></div>
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	964416000	USD
CY2022Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	52248000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1609919000	USD
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	118058000	USD
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-31387000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	966091000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1675000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	964416000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	119156000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	113197000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23172000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19680000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	95984000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	93517000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15717000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16074000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12847000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	51401000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2646000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2531000	USD
CY2022Q1	aur	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	31210000	USD
CY2021Q4	aur	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	70006000	USD
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	97500000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	51000000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	aur	Derivative Instrument Warrant Liability Written Notice Of Redemption Period DerivativeInstrumentWarrantLiabilityWrittenNoticeOfRedemptionPeriod	P30D
CY2021Q4	aur	Derivative Instrument Warrant Liability Written Notice Of Redemption Period DerivativeInstrumentWarrantLiabilityWrittenNoticeOfRedemptionPeriod	P30D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	75948673	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	81405867	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	147424419	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	122487648	shares
CY2022Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	310927831	shares
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	259066648	shares
CY2021Q4	aur	Derivative Instrument Warrant Liability Written Notice Of Redemption Period DerivativeInstrumentWarrantLiabilityWrittenNoticeOfRedemptionPeriod	P30D
CY2022Q1	aur	Derivative Instrument Contingent Consideration Liability Earnout Shares Amount DerivativeInstrumentContingentConsiderationLiabilityEarnoutSharesAmount	20993000	USD
CY2021Q4	aur	Derivative Instrument Contingent Consideration Liability Earnout Shares Amount DerivativeInstrumentContingentConsiderationLiabilityEarnoutSharesAmount	52380000	USD
CY2022Q1	aur	Derivative Instrument Contingent Consideration Liability Earnout Shares Vested During The Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutSharesVestedDuringThePeriod	0	shares
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	31114000	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29247000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	36895000	USD
CY2021Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y4M24D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0626
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	6862000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	6070000	USD
CY2021Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2022Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2262000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	191000	USD
CY2022Q1	aur	Vesting Of Early Exercised Stock Options VestingOfEarlyExercisedStockOptions	11000	USD
CY2021Q1	aur	Vesting Of Early Exercised Stock Options VestingOfEarlyExercisedStockOptions	111000	USD
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	0	USD
CY2021Q1	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	-1939804000	USD
CY2022Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1369000	USD
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	540000	USD
CY2022Q1	us-gaap	Due From Related Parties DueFromRelatedParties	0	USD
CY2021Q4	us-gaap	Due From Related Parties DueFromRelatedParties	10726000	USD

Files In Submission

Name	View Source	Status
0001828108-22-000046-index-headers.html	Edgar Link	pending
0001828108-22-000046-index.html	Edgar Link	pending
0001828108-22-000046.txt	Edgar Link	pending
0001828108-22-000046-xbrl.zip	Edgar Link	pending
a22q110-qex311.htm	Edgar Link	pending
a22q110-qex312.htm	Edgar Link	pending
a22q110-qex321.htm	Edgar Link	pending
a22q110-qex322.htm	Edgar Link	pending
aur-20220331.htm	Edgar Link	pending
aur-20220331.xsd	Edgar Link	pending
aur-20220331_cal.xml	Edgar Link	unprocessable
aur-20220331_def.xml	Edgar Link	unprocessable
aur-20220331_htm.xml	Edgar Link	completed
aur-20220331_lab.xml	Edgar Link	unprocessable
aur-20220331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AUR
Aurora Innovation, Inc. Stock $aur

2022 Q1 Form 10-Q Financial Statement

#000182810822000046 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AUR Aurora Innovation, Inc. Stock $aur

2022 Q1 Form 10-Q Financial Statement

#000182810822000046 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AUR
Aurora Innovation, Inc. Stock $aur